Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIDENT Triple Pill Trial after Intracerebral Hemorrhage
NL-OMON54804Phase 3Completed
- Sponsor
- The George Institute for Global Health
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of telmisartan, amlodipine and indapamide in intracerebral hemorrhage (ICH), sponsored by The George Institute for Global Health. Primary endpoint: Time to first recurrent stroke. Started May 2018; status: completed.
02
Drugs
telmisartanamlodipineindapamide
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NL-OMON54804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54804.